---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-039073"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:58:01.975059+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CEO resigns, then reappointed; board resignations trigger Nasdaq non-compliance

## Summary
- CEO Dr. Angel resigned Aug 4 citing board's exclusion from business dev; rescinded Aug 8, reappointed Aug 9.
- Directors Binder and Wagner resigned Aug 8; Board reduced to two members (Wexler, Fiore).
- Nasdaq notified non-compliance with independent director, audit & compensation committee rules.
- Company has 45 days to submit compliance plan; up to 180-day extension possible if plan accepted.
- Company actively searching for new directors to fill vacancies and regain compliance.

## SEC filing metadata
- accession: 0001140361-23-039073
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/0001140361-23-039073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/brhc20057343_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-039073
- JSON: https://secwatch.observer/filing/0001140361-23-039073.json
- Plain text: https://secwatch.observer/filing/0001140361-23-039073.txt

## Key facts
- Executive change
  Richard W. Wagner resigned as Director at Ernexa Therapeutics Inc..
  - Action: resigned
  - Role: Director
  source text: On August 8, 2023, Mr. Brant C. Binder and Dr. Richard W. Wagner resigned from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/0001140361-23-039073-index.htm
- Executive change
  Brant C. Binder resigned as Director at Ernexa Therapeutics Inc..
  - Action: resigned
  - Role: Director
  source text: On August 8, 2023, Mr. Brant C. Binder and Dr. Richard W. Wagner resigned from the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/0001140361-23-039073-index.htm
- Executive change
  Matthew Angel resigned as President and Chief Executive Officer at Ernexa Therapeutics Inc..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: On August 4, 2023, Dr. Matthew Angel resigned from the Board and as the Company’s President and Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/0001140361-23-039073-index.htm
- Executive change
  Matthew Angel was appointed as President and Chief Executive Officer at Ernexa Therapeutics Inc..
  - Action: reappointed
  - Role: President and Chief Executive Officer
  source text: the Board reappointed Dr. Angel as the Company’s President and Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036123039073/0001140361-23-039073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.